| Hot-Stocks Übersicht |
| SAMSUNG VZ Aktie | +12,38% |
| LEVI STRAUSS Aktie | +10,20% |
| REDCARE Aktie | +10,03% |
| BARCLAYS Aktie | +8,81% |
| DELTA AIR LINES Aktie | +8,66% |
| COMMERZBANK Aktie | +8,40% |
| MICRON Aktie | +6,94% |
| UNICREDIT Aktie | +6,91% |
| BNP PARIBAS Aktie | +6,88% |
| STELLANTIS Aktie | +6,65% |
| INTEL Aktie | +6,13% |
| EVOTEC Aktie | +5,81% |
| ALIBABA ADR Aktie | +5,03% |
| UBS Aktie | +4,85% |
| MORGAN STANLEY Aktie | +4,75% |
| GOLDMAN SACHS Aktie | +4,48% |
| SONY Aktie | +4,31% |
| META PLATFORMS Aktie | +3,53% |
| BROADCOM Aktie | +3,42% |
| JPMORGAN Aktie | +3,12% |
| ALPHABET A Aktie | +3,09% |
| BANK OF AMERICA Aktie | +2,40% |
| AMAZON Aktie | +2,34% |
| UNIVERSAL MUSIC Aktie | +2,34% |
| FORD Aktie | +2,33% |
| NVIDIA Aktie | +2,22% |
| ALLIANZ Aktie | +2,16% |
| ORACLE Aktie | +2,04% |
| SHELL Aktie | -4,65% |
| EXXON MOBIL Aktie | -7,11% |
| ZURA BIO LTD CL.A |
| China |
| Gesundheit |
| KYG9TY5A1016 / A3D7LY |
| 94E (Frankfurt) / ZURA (NASDAQ) |
| FRA:94E, ETR:94E, 94E:GR, NASDAQ:ZURA |
| - |
| https://zurabio.com/ |
|
Zura Bio Ltd. is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. The company focuses on advancing a pipeline that includes tibulizumab (ZB-106), a bispecific antibody..
>Volltext.. |
| 459.08 Mio. EUR |
| 365.39 Mio. EUR |
| - |
| -64.4 Mio. EUR |
| -85.08 Mio. EUR |
| -1.02 EUR |
| - |
| 93.69 Mio. EUR |
| -55.51 Mio. EUR |
| 8.82 |
| - |
| -118.91% |
| - |
| - |
| - |
| - |
| ZURA BIO, ZURABIO |
| 08.04.26 |
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
